Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism

Journal of Physiology and Biochemistry

Volumn 71, Issue 4, 2015, Pages 679-689

  Vaughan, Roger A ^a,b,c   Gannon, Nicholas P ^c,d   Mermier, Christine M ^b   Conn, Carole A ^b  

^a HIGH POINT UNIVERSITY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Fibronectin type III domain containing protein 5 (FNDC5); Interleukin 6 (IL6); Peroxisome proliferator activated receptor coactivator 1 (PGC 1 ); Secretome; Tumor necrosis factor (TNF )

Indexed keywords

GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; IRISIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; FIBRONECTIN; FNDC5 PROTEIN, MOUSE;

ACIDIFICATION; AEROBIC METABOLISM; ANIMAL CELL; ARTICLE; C2C12 CELL LINE; CELL STRESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENERGY EXPENDITURE; FLUORESCENCE ANALYSIS; GENE EXPRESSION REGULATION; GLYCOLYSIS; IMMUNOBLOTTING; IN VITRO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; MOUSE; MUSCLE METABOLISM; MYOTUBE; NONHUMAN; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXYGEN CONSUMPTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL LINE; CYTOLOGY; GENE EXPRESSION; METABOLISM; PHYSIOLOGY; SKELETAL MUSCLE; SKELETAL MUSCLE CELL;

ANIMALS; CELL LINE; FIBRONECTINS; GENE EXPRESSION; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; NF-KAPPA B; OXYGEN CONSUMPTION;

EID: 84949321642     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-015-0433-9     Document Type: Article

References (53)

1. Abd TT, Jacobson TA (2011) Statin-induced myopathy: a review and update. Expert Opin Drug Saf 10:373–387
2. Albrecht E, Norheim F, Thiede B, Holen T, Ohashi T, Schering L et al (2015) Irisin - a myth rather than an exercise-inducible myokine. Sci Rep 5:8889
3. Aydin S, Aydin S, Kuloglu T, Yilmaz M, Kalayci M, Sahin I et al (2013) Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running. Peptides 50:13–18
4. Aydin S, Kuloglu T, Aydin S, Kalayci M, Yilmaz M, Cakmak T et al (2014) A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides 61:130–136
5. Bhatnagar S, Panguluri SK, Gupta SK, Dahiya S, Lundy RF, Kumar A (2010) Tumor necrosis factor-a regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLoS One 5(10):e13262
6. Bostroem P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC et al (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–U72
7. Castillo-Quan JI (2012) From white to brown fat through the PGC-1 alpha-dependent myokine irisin: implications for diabetes and obesity. Dis Model Mech 5:293–295
8. Daskalopoulou SS, Cooke AB, Gomez Y-H, Mutter AF, Filippaios A, Mesfum ET et al (2014) Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects. Eur J Endocrinol 171:343–352
9. Ellefsen S, Vikmoen O, Slettalokken G, Whist JE, Nygaard H, Hollan I et al (2014) Irisin and FNDC5: effects of 12-week strength training, and relations to muscle phenotype and body mass composition in untrained women. Eur J Appl Physiol 114:1875–1888
10. Erickson HP (2013) Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocytes 2:289–293
11. Evans MJ, Scarpulla RC (1990) NRF-1—a transactivtor of nuclear-encoded respiratory genes in animal-cells. Genes Dev 4(6):1023–1034
12. Gannon NP, Vaughan RA, Garcia-Smith R, Bisoffi M, Trujillo KA (2014) Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer 136(4):E197–E202
13. Giulivi C, Ross-Inta C, Horton AA, Luckhart S (2008) Metabolic pathways in anopheles stephensi mitochondria. Biochem J 415(2):309–316
14. Gleyzer N, Vercauteren K, Scarpulla RC (2005) Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol Cell Biol 25:1354–1366
15. Gouni-Berthold I, Berthold HK, Huh JY, Berman R, Spenrath N, Krone W et al (2013) Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo (2013). PLoS One 8(9):e72858
16. Ho RC, Hirshman MF, Li YF, Cai DS, Farmer JR, Aschenbach WG et al (2005) Regulation of I kappa B kinase and NF-kappa B in contracting adult rat skeletal muscle. Am J Physiol Cell Physiol 289:C794–C801
17. Huh JY, Mougios V, Kabasakalis A, Fatouros I, Siopi A, Douroudos II et al (2014) Exercise-induced irisin secretion is independent of Age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. J Clin Endocrinol 99:E2154–E2161
18. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE et al (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. MRNA expression and circulating concentrations in response to weight loss and exercise. Metab Clin Exp 61:1725–1738
19. Kalinkovich A, Livshits G (2015) Sarcopenia—the search for emerging biomarkers. Ageing Res Rev 22:58–71
20. Kelly DP (2012) Irisin, light my fire. Science 336:42–43
21. Kelly M, Gauthier M-S, Saha AK, Ruderman NB (2009) Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle association with changes in cAMP, energy state, and endogenous fuel mobilization. Diabetes 58:1953–1960
22. Knutti D, Kaul A, Kralli A (2000) A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol Cell Biol 20:2411–2422
23. Komolka K, Albrecht E, Schering L, Brenmoehl J, Hoeflich A, Maak S (2014) Locus characterization and gene expression of bovine FNDC5: is the myokine irisin relevant in cattle? PLoS One 9(1):e88060
24. Kramer HF, Goodyear LJ (2007) Exercise, MAPK, and NF-kappa B signaling in skeletal muscle. J Appl Physiol 103:388–395
25. Kunsch C, Rosen CA (1993) NF-kappa-B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 13:6137–6146
26. Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L et al (2014) Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol 592:1091–1107
27. Lecker SH, Zavin A, Cao P, Arena R, Allsup K, Daniels KM et al (2012) Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail 5:812–818
28. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F et al (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol 98:E769–E778
29. Park M, Kim D, Choi J, Heo Y, Park S (2015) New role of irisin in hepatocytes: the protective effect of hepatic steatosis in vitro. Cell Signal 27(9):1831–1839
30. Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE et al (2013) Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol 98:4899–4907
31. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45
32. Polyzos S, Kountouras J, Shields K, Mantzoros C (2013) Irisin: a renaissance in metabolism? Metabolism 62:1037–1044
33. Polyzos S, Mantzoros C (2015) An update on the validity of irisin assays and the link between irisin and hepatic metabolism. Metabolism S0026–0495(15):00166–3
34. Pothineni NV, Ding Z, Mehta JL (2013) Is irisin an early marker of statin-induced myopathy? bench to the bedside. C Clin Lipidol 8:623–625
35. Puigserver P, Rhee J, Lin JD, Wu ZD, Yoon JC, Zhang CY et al (2001) Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPAR gamma coactivator-1. Mol Cell 8(5):971–982
36. Sathasivam S (2012) Statin induced myotoxicity. Eur J Intern Med 23:317–324
37. Sathasivam S, Lecky B (2008) Statin induced myopathy. BMJ 337:a2286
38. Scarpulla RC (2002) Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 286(1):81–89
39. Scharhag-Rosenberger F, Meyer T, Wegmann M, Ruppenthal S, Kaestner L, Morsch A et al (2014) Irisin does not mediate resistance training-induced alterations in resting metabolic rate. Med Sci Sports Exerc 46:1736–1743
40. Scheler M, Irmler M, Lehr S, Hartwig S, Staiger H, Al-Hasani H et al (2013) Cytokine response of primary human myotubes in an in vitro exercise model. Am J Physiol Cell Physiol 305:C877–C886
41. Singh P, Kohr D, Kaps M, Blaes F (2010) Skeletal muscle cell MHC I expression: implications for stain-induced myopathy. Muscle Nerve 41:179–184
42. Timmons JA, Baar K, Davidsen PK, Atherton PJ (2012) Is irisin a human exercise gene? Nature 488:E9–E10
43. Vaughan RA, Gannon NP, Barberena MA, Garcia-Smith R, Bisoffi M, Mermier CM et al (2014) Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab 16:711–718
44. Vaughan RA, Garcia-Smith R, Bisoffi M, Conn CA, Trujillo KA (2013) Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis. Eur J Pharmacol 711(1–3):1–9
45. Vaughan RA, Garcia-Smith R, Gannon NP, Bisoffi M, Trujillo KA, Conn CA (2013) Leucine treatment enhances oxidative capacity through complete carbohydrate oxidation and increased mitochondrial density in skeletal muscle cells. Amino Acids 45(4):901–911
46. Vella L, Caldow MK, Larsen AE, Tassoni D, Della Gatta PA, Gran P et al (2012) Resistance exercise increases NF-kappa B activity in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 302:R667–R673
47. Villarroya F (2012) Irisin, turning up the heat. Cell Metab 15:277–278
48. Virbasius JV, Scarpulla RC (1994) Activation of the human mitochondrial transcription factor a gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene-expression in organelle biosynthesis. Proc Natl Acad Sci U S A 91(4):1309–1313
49. Wang C, Wang L, Li W, Yan F, Tian M, Wu C et al (2015) Irisin has no effect on lipolysis in 3T3-L1 adipocytes or fatty acid metabolism in HepG2 hepatocytes. Endocrine 49(1):90–96
50. Wikstrom JD, Sereda SB, Stiles L, Elorza A, Allister EM, Neilson A et al (2012) A novel high-throughput assay for islet respiration reveals uncoupling of rodent and human islets. PLoS One 7(5):e33023
51. Wu H, Kanatous SB, Thurmond FA, Gallardo T, Isotani E, Bassel-Duby R et al (2002) Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296:349–352
52. Wu ZD, Puigserver P, Andersson U, Zhang CY, Adelmant G, Mootha V et al (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115–124
53. Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y et al (2014) Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 63:514–525